Fidelity SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 298
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
U.s. Private Sector Adds 213,000 Jobs
Private payrolls in the U.S. increased by 213,000 jobs in September, according to an employment survey released by ADP. Manufacturing hiring was particularly strong.
More Top Equities Stories Of The Day
JAL Customer Data Target of Cyber Attack
Bank of America Board Gives Chairman Job to Brian Moynihan
IPO Scorecard: Update on Selected Initial Stock Offerings
Intel Invests in Chinese Chip Maker -- Update
Reserve Bank of India Holds Rate
Bank Branches in U.S. Decline to Lowest Level Since 2005
U.S. Hot Stocks: Hot Stocks to Watch
Starboard Pushes For Potential Yahoo-AOL Tie-Up -- 5th Update
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 645884 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist